The Clorox Company (NYSE:CLX) Shares Purchased by Czech National Bank
The Clorox Company (NYSE:CLX) Shares Purchased by Czech National Bank
Czech National Bank boosted its position in The Clorox Company (NYSE:CLX – Get Rating) by 0.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,442 shares of the company's stock after buying an additional 129 shares during the quarter. Czech National Bank's holdings in Clorox were worth $2,027,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in Clorox by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 14,685,046 shares of the company's stock worth $2,041,661,000 after buying an additional 185,012 shares in the last quarter. BlackRock Inc. raised its stake in shares of Clorox by 5.6% in the 3rd quarter. BlackRock Inc. now owns 10,964,049 shares of the company's stock valued at $1,407,673,000 after purchasing an additional 580,982 shares in the last quarter. State Street Corp raised its stake in shares of Clorox by 9.6% in the 2nd quarter. State Street Corp now owns 8,907,083 shares of the company's stock valued at $1,255,721,000 after purchasing an additional 778,269 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of Clorox by 2.4% in the 2nd quarter. Wells Fargo & Company MN now owns 3,557,161 shares of the company's stock valued at $501,489,000 after purchasing an additional 82,698 shares in the last quarter. Finally, Federated Hermes Inc. raised its stake in shares of Clorox by 11.1% in the 3rd quarter. Federated Hermes Inc. now owns 2,161,323 shares of the company's stock valued at $277,492,000 after purchasing an additional 215,425 shares in the last quarter. Institutional investors and hedge funds own 79.12% of the company's stock.
Get Clorox alerts:Clorox Price Performance
NYSE CLX opened at $157.50 on Friday. The Clorox Company has a 52 week low of $120.50 and a 52 week high of $160.59. The company has a current ratio of 0.86, a quick ratio of 0.47 and a debt-to-equity ratio of 5.04. The stock has a market cap of $19.46 billion, a price-to-earnings ratio of 45.00, a price-to-earnings-growth ratio of 3.12 and a beta of 0.29. The company has a 50-day moving average price of $150.56 and a two-hundred day moving average price of $144.96.
Clorox (NYSE:CLX – Get Rating) last posted its earnings results on Thursday, February 2nd. The company reported $0.98 EPS for the quarter, topping the consensus estimate of $0.66 by $0.32. Clorox had a net margin of 6.16% and a return on equity of 89.97%. The firm had revenue of $1.72 billion during the quarter, compared to analysts' expectations of $1.66 billion. During the same quarter in the prior year, the firm earned $0.66 EPS. Clorox's quarterly revenue was up 1.4% on a year-over-year basis. Analysts forecast that The Clorox Company will post 4.23 EPS for the current year.
Clorox Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, May 12th. Shareholders of record on Wednesday, April 26th will be given a $1.18 dividend. This represents a $4.72 annualized dividend and a yield of 3.00%. The ex-dividend date is Tuesday, April 25th. Clorox's dividend payout ratio (DPR) is 134.86%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on the stock. Barclays cut their target price on shares of Clorox from $110.00 to $108.00 and set an "underweight" rating on the stock in a research note on Monday, February 6th. JPMorgan Chase & Co. upped their target price on shares of Clorox from $126.00 to $135.00 and gave the company an "underweight" rating in a research note on Friday, January 13th. StockNews.com assumed coverage on shares of Clorox in a research note on Thursday, March 16th. They issued a "hold" rating on the stock. Jefferies Financial Group upped their target price on shares of Clorox from $140.00 to $145.00 and gave the company a "hold" rating in a research note on Wednesday, February 1st. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Clorox from $152.00 to $147.00 in a research note on Monday, March 20th. Seven equities research analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $141.00.
Clorox Profile
(Get Rating)
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.
Featured Articles
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- MarketBeat Week in Review – 3/20 – 3/24
- Dividend King Genuine Parts Company Upgraded On Profit Guidance
- The Bottom Is In For Accenture
- 11 Best Consumer Discretionary Stocks of 2023
- 5 Best Dividend Capture Stocks
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Get Rating).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
根据捷克国家银行提交给美国证券交易委员会(美国证券交易委员会)的最新13F文件,第四季度捷克国家银行将其在高乐氏公司(纽约证券交易所代码:CLX-GET评级)的头寸提高了0.9%。该机构投资者在本季度额外购买了129股后,持有该公司14,442股股票。截至最近一个季度末,捷克国家银行持有的Clorox股份价值202.7万美元。
其他一些机构投资者最近也增持或减持了该公司的股份。先锋集团(Vanguard Group Inc.)第一季度增持高乐氏1.3%的股份。先锋集团现在持有14,685,046股该公司股票,价值2,041,661,000美元,上个季度又购买了185,012股。贝莱德股份有限公司在第三季度增持了高乐氏5.6%的股份。贝莱德股份有限公司在上个季度购买了580,982股后,现在持有10,964,049股该公司股票,价值1,407,673,000美元。道富银行在第二季度增持了9.6%的高乐氏股票。道富银行目前持有8,907,083股该公司股票,价值1,255,721,000美元,上一季度又购买了778,269股。富国银行MN在第二季度增持了2.4%的高乐氏股票。Wells Fargo&Company MN在上个季度额外购买了82,698股后,现在拥有3,557,161股该公司股票,价值501,489,000美元。最后,联合爱马仕公司在第三季度增持了高乐氏11.1%的股份。联合爱马仕公司目前持有该公司2,161,323股股票,价值277,492,000美元,上个季度又购买了215,425股。机构投资者和对冲基金持有该公司79.12%的股票。
到达高乐氏警报:高乐氏性价比
纽约证交所CLX上周五开盘报157.50美元。高乐氏公司目前的52周低点为120.50美元,52周高点为160.59美元。该公司的流动比率为0.86,速动比率为0.47,债务权益比率为5.04。该股市值为194.6亿美元,市盈率为45.00倍,市盈率为3.12倍,贝塔系数为0.29。该公司的50日移动均线价格为150.56美元,200日移动均线价格为144.96美元。
高乐氏(纽约证券交易所代码:CLX-GET Rating)最近一次公布财报是在2月2日星期四。该公司公布本季度每股收益为0.98美元,比普遍预期的0.66美元高出0.32美元。高乐氏的净利润率为6.16%,股本回报率为89.97%。该公司本季度营收为17.2亿美元,高于分析师预期的16.6亿美元。去年同期,该公司每股收益为0.66美元。高乐氏季度营收同比增长1.4%。分析师预测,高乐氏公司本年度每股收益将达到4.23欧元。
高乐氏股息公告
该公司最近还宣布了季度股息,将于5月12日(星期五)支付。4月26日(星期三)登记在册的股东将获得1.18美元的股息。这意味着年化股息为4.72美元,收益率为3.00%。除息日期为4月25日(星期二)。高乐氏的股息支付率为134.86。
华尔街分析师预测经济增长
一些股票研究分析师最近发布了关于该股的报告。巴克莱将高乐氏股票的目标价从110.00美元下调至108.00美元,并在2月6日周一的一份研究报告中将该股的评级定为“减持”。摩根大通将高乐氏股票的目标价从126.00美元上调至135.00美元,并在1月13日星期五的一份研究报告中给出了该公司“减持”的评级。斯托克新闻网在3月16日星期四的一份研究报告中对高乐氏的股票进行了报道。他们对该股的评级为“持有”。2月1日周三,杰富瑞金融集团将高乐氏股票的目标价从140.00美元上调至145.00美元,并在一份研究报告中给予该公司“持有”评级。最后,德意志银行Aktiengesellschaft在3月20日星期一的一份研究报告中将高乐氏股票的目标价从152.00美元下调至147.00美元。7名股票研究分析师对该股的评级为卖出,6名分析师给予持有评级,1名分析师对该股给予买入评级。根据MarketBeat.com的数据,该公司的共识评级为持有,共识目标价为141.00美元。
高乐氏简介
(获取评级)
高乐氏公司从事消费品和专业产品的制造和营销。它通过以下业务部门运营:健康和健康、家庭、生活方式和国际。健康和健康部分包括清洁产品、专业产品和维生素、矿物质和补充剂,主要在美国销售和销售。
专题文章
- 免费获取StockNews.com关于高乐氏的研究报告
- 市场回顾周-3/20-3/24
- 红利王正品配件公司利润指引升级
- 埃森哲的底部已经到了
- 2023年11只最佳非必需消费品股票
- 5只最佳股利捕捉股
想看看还有哪些对冲基金持有CLX吗?访问HoldingsChannel.com,获取高乐氏公司(纽约证券交易所代码:CLX-GET评级)的最新13F文件和内幕交易。
接受《高乐氏日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Clorox和相关公司的最新新闻和分析师评级的每日简要摘要。
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧